RPB Walt and Lilly Disney Award for Amblyopia Research
RPB Walt and Lilly Disney Award for Amblyopia Research supports ophthalmic scientists conducting independent research on amblyopia’s pathophysiology, diagnosis, or treatment to improve diagnosis and care.
Funder: Research to Prevent Blindness
Due Dates: December 15, 2026 (Nomination) | January 10, 2027 (Application, 11:59 p.m. ET)
Funding Amounts: $150,000 total across one or two annual awards; funds must be spent within two years
Summary: Supports independent research of unusual significance and promise related to amblyopia pathophysiology, diagnosis, and/or treatment.
Key Information: Prior department-chair nomination is required, with only one candidate nominated per department.
Description
Research to Prevent Blindness (RPB) offers this award to strengthen and promote research that improves the diagnosis and/or treatment of amblyopia. It supports exceptional ophthalmic scientists conducting investigations of unusual significance and promise, with a clear connection to amblyopia’s pathophysiology, diagnosis, and/or treatment.
The program is intended for investigators at different stages of their academic careers, from Assistant Professor through full Professor, whose proposals reflect independent research. Applicants should explain the relationship between their proposed work and amblyopia, including its clinical relevance. The proposed research objectives, the scientist’s expertise and accomplishments, and the planned use of RPB funds are addressed through the application and supporting statements.
